previous compound ID: 1573 next compound
InChIKey: OFCNXPDARWKPPY-UHFFFAOYSA-N
SMILES: C1=C2C(=NC=NC2=O)NN1

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "DY Thomas" "E Matthes" "JW Hanrahan" "GW Carlile" "J Liao" "J Goepp" "SD Macknight" "D Rotin" "R Robert"

chemical graph of compound 1573





CID is 2094
synonyms found at PubChem are:
allopurinol, 315-30-0, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol, Zyloprim, Zyloric, Lopurin, Atisuril, Bleminol, Caplenal, Uripurinol, Embarin, Foligan, Milurit, Progout, Urosin, Anoprolin, Cellidrin, Epidropal, Suspendol, Ailural, Allopur, Allural, Alositol, Bloxanth, Cosuric, Hamarin, Ledopur, Lysuron, Uricemil, Uriprim, Xanturat, Aloral, Anzief, Apurin, Apurol, Geapur, Gotax, Remid, Urbol, Urolit, Urtias, Ketobun-A, Apulonga, Dabrosin, Dabroson, Ketanrift, Miniplanor, Nektrohan, Takanarumin, Urobenyl, Adenock, Allozym, Aluline, Gichtex, Monarch, Riball, Hexanuret, Epuric, 4-Hydroxypyrazolo[3,4-d]pyrimidine, 1H-Pyrazolo[3,4-d]pyrimidin-4(5H)-one, Allo-Puren, 4-HPP, Allopurinol(I), Dura Al, Allopurinolum, Alopurinol, Aloprim, 4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine, Urtias 100, 4-Hydroxypyrazolopyrimidine, 1H-Pyrazolo(3,4-d)pyrimidin-4-ol, 4-Hydroxy-3,4-pyrazolopyrimidine, 4-Hydroxypyrazolo(3,4-d)pyrimidine, Alopurinol [INN-Spanish], Allopurinolum [INN-Latin], 4-Hydroxypyrazolyl(3,4-d)pyrimidine, 4H-Pyrazolo(3,4-d)pyrimidin-4-one, Allohexal, Milurite, Purinol, Sigapurol, Uritas, 4'-Hydroxypyrazolol(3,4-d)pyrimidine, NSC-1390, AL-100, Zyloprim (TN), 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one, 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, BW 56-158, Ailurial, B. W. 56-158, Apo-Allopurinol, 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one, BW-56-158, UNII-63CZ7GJN5I, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-, NSC 1390, 180749-08-0, CCRIS 626, NSC 101655, MLS000069453, 180749-06-8, 4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-, CHEBI:40279, 1H-pyrazolo[3,4-d]pyrimidin-4(7H)-one, HSDB 3004, 1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one, EINECS 206-250-9, 2H-Pyrazolo[3,4-d]pyrimidin-4-ol, 73334-58-4, 916980-04-6, 63CZ7GJN5I, BW-56158, SMR000059083, ALLOPURINOL SODIUM, NSC1390, OFCNXPDARWKPPY-UHFFFAOYSA-N, 4H-Pyrazolo[3,4-d]pyrimidin-4-one,1,2-dihydro-, NSC101655, 180749-07-9, 180749-09-1, 184789-03-5, 4-Hydroxypyrazolo-[3,4-d]-pyrimidine, NCGC00015094-02, NCGC00094580-04, 4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine, BW 56158, 1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one, 1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one, 1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one, 1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one, 1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one, DSSTox_CID_2573, A 8003, DSSTox_RID_76636, DSSTox_GSID_22573, pyrazolo[5,4-d]pyrimidin-4-ol, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro- (9CI), 4H-Pyrazolo[3, 1,5-dihydro-, Jenapurinol, Rimapurinol, Allohexan, Alloprin, Allopurin, Allorin, Allpargin, Capurate, Novopurol, Pureduct, Tipuric, Uribenz, Uridocid, WLN: T56 BMN GN INJ FQ, Xanthomax, Xanturic, Roucol, Zygout, 4-Hydroxypyrazolyl[3,4-d]pyrimidine, Pan Quimica, 4'-Hydroxypyrazolol[3,4-d]pyrimidine, CAS-315-30-0, SR-05000001983, 291279-53-3, Hexanurat, Uricto, ATH008, Quimica, Pan, Lopurin, Zyloprim, Allohexal (TN), Allopurinol [USAN:INN:BAN:JAN], Prestwick_511, Xanthomax-100, Xanthomax-300, Allosig (TN), Progout (TN), Puricos (TN), Zyloric (TN), ALLO, Aluline 100, Aluline 300, Hamarin 100, Hamarin 300, Zyloric-300, Allopurinol [USAN:USP:INN:BAN:JAN], Allopurinol (Zyloprim), PubChem13052, Spectrum_000026, AC1L1CWL, AC1Q6FWV, Opera_ID_1680, Spectrum2_000098, Spectrum3_000289, Spectrum4_000135, Spectrum5_000768, Lopac-A-8003, 1,4-d]pyrimidin-4-one, D04KYY, AC1Q6GP7, cid_2094, SCHEMBL4627, CHEMBL1467, NCIOpen2_001825, Lopac0_000102, BSPBio_001798, KBioGR_000550, KBioSS_000386, KSC171E0R, MLS001148183, US9138393, Allopurinol, US9144538, Allopurinol, DivK1c_000685, SPECTRUM1500108, SPBio_000056, GTPL6795, SCHEMBL1128219, Allopurinol (JP17/USP/INN), Jsp005881, DTXSID4022573, BDBM35440, CTK0H1208, CTK0H1209, CTK5D7801, CTK8H3286, HMS502C07, KBio1_000685, KBio2_000386, KBio2_002954, KBio2_005522, KBio3_001298, MolPort-000-141-383, MolPort-000-870-337, MolPort-003-844-438, MolPort-004-758-643, NINDS_000685, BDBM181133, HMS1920A15, HMS2091G15, HMS2234M09, HMS3259K13, HMS3260E06, HMS3371I11, HMS3651O13, HMS3714L22, Pharmakon1600-01500108, 4-Hydroxypyrazol[3,4-D]pyrimidine, ACT02732, BCP26973, H-Pyrazolo(3,4-d)pyrimidin-4-ol, HY-B0219, STR05189, Tox21_110082, Tox21_200922, Tox21_500102, 2204AH, 4-Hydroxy-pyrazolo[3,4-d]pyrimidin, AC-019, BBL002902, BBL009959, BDBM50016784, BDBM50140241, CCG-38916, CH-782, MFCD00599413, NSC755858, s1630, SBB004202, SC1118, SC2251, STK378584, STK711106, ZINC13298313, AKOS000267490, AKOS000269759, AKOS009031129, AKOS024255717, AKOS030537567, Tox21_110082_1, Allopurinol, xanthine oxidase inhibitor, CCG-204197, CCG-221406, CS-2166, DB00437, LP00102, LS-1180, MCULE-5186178136, NC00492, NSC-101655, NSC-755858, RP01074, RP08415, RTC-063550, TRA0028733, IDI1_000685, NCGC00015094-01, NCGC00015094-03, NCGC00015094-04, NCGC00015094-05, NCGC00015094-06, NCGC00015094-07, NCGC00091134-01, NCGC00091134-02, NCGC00091134-03, NCGC00094580-01, NCGC00094580-02, NCGC00094580-05, NCGC00188948-01, NCGC00258476-01, NCGC00260787-01, AJ-63598, AN-16214, BC202911, BR-49674, CPD000059083, EN000932, KB-65326, SAM002554884, SC-16544, TS-00028, 2h-pyrazolo[3,4-d]pyrimidin-4(5h)-one, 2H-pyrazolo[3,4-d]pyrimidin-4(7H)-one, SBI-0050090.P004, AB0006119, AB0011633, AB0088254, AB1001755, DB-065332, KB-172537, KB-192347, KB-192357, KB-192358, KB-192361, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI), A0907, EU-0100102, FT-0602537, FT-0685730, FT-0764079, ST45179105, 1,5-dihydropyrazolo[3,4-d]-pyrimidin-4-one, VU0611037-1, BIM-0061756.0001, D00224, L-1944, Q-1018, 32298-EP2272832A1, 32298-EP2281815A1, 32298-EP2292227A2, 32298-EP2292630A1, 32298-EP2295426A1, 32298-EP2295427A1, 32298-EP2301933A1, 32298-EP2305219A1, 32298-EP2305640A2, 32298-EP2311825A1, 32298-EP2311827A1, AB00173448-03, AB00173448-04, AB00173448_05, AB01274719-01, AB01274719_02, 4h-pyrazolo[3,4-d]pyrimidin-4-one,1,7-dihydro-, 4h-pyrazolo[3,4-d]pyrimidin-4-one,2,5-dihydro-, 4h-pyrazolo[3,4-d]pyrimidin-4-one,2,7-dihydro-, AB-323/25048497, Allopurinol (4-Hydroxypyrazolo[3,4-d]pyrimidine), SR-01000075595, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,2-dihydro-, 4H-pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro-, I03-0052, J-504736, SR-01000075595-1, SR-05000001983-1, SR-05000001983-2, W-106892, 1,7-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE, 1,2-DIHYDRO-4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE, 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one (9CI), F2173-0394, F3329-0375, Z228474686, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro- (9CI), 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,7-dihydro- (9CI), Allopurinol, British Pharmacopoeia (BP) Reference Standard, Allopurinol, European Pharmacopoeia (EP) Reference Standard, Allopurinol, United States Pharmacopeia (USP) Reference Standard, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-, labeled with deuterium, Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10, 184856-42-6, 22767-92-6, 39464-14-7, tautomeric mixture of 1H-pyrazolo[3,4-d]pyrimidin-4-ol and 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one